Approvals/TGA/INDOSYL COMBI 4/1.25 perindopril erbumine 4mg / indapamide hemihydrate 1.25mg tablet blister pack

Approved

STANDARD

INDOSYL COMBI 4/1.25 perindopril erbumine 4mg / indapamide hemihydrate 1.25mg tablet blister pack

Servier Laboratories (Aust) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f3e5f9636d048f29
Product Name: INDOSYL COMBI 4/1.25 perindopril erbumine 4mg / indapamide hemihydrate 1.25mg tablet blister pack
Artg Id: 74137
Artg Name: INDOSYL COMBI 4/1.25 perindopril erbumine 4mg / indapamide hemihydrate 1.25mg tablet blister pack
Sponsor: Servier Laboratories (Aust) Pty Ltd
Company Detail Path: /organization/servier-laboratories-aust-pty-ltd
Artg Date: 2000-05-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b4ebde08e5cda6fd6b4f5c33488d3522.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8586accc365a39ae43ed0490e4928a43.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

f3e5f9636d048f29

Type

Standard